CAJ | 학술논문

心肌纤维化是高血压性心脏病的病理基础，是控制高血压心血管并发症的关键。现代医学只是针对单一的病理环节进行干预，中医药具有多成分、多途径、多靶点综合干预的优势，从不同的角度探讨中医药干预高血压心肌纤维化的效应和机制，可为高血压心肌纤维化的临床治疗提供参考。
심기섬유화시고혈압성심장병적병리기출，시공제고혈압심혈관병발증적관건。현대의학지시침대단일적병리배절진행간예，중의약구유다성분、다도경、다파점종합간예적우세，종불동적각도탐토중의약간예고혈압심기섬유화적효응화궤제，가위고혈압심기섬유화적림상치료제공삼고。
Myocardial fibrosis is the pathological basis of hypertensive heart disease, which is the key to control cardiovascular complications. Traditional Chinese medicine (TCM) has the advantage of targeting many components of a system and providing more integrated regulation than modern medicine. While, modern medicine tends to target a single pathological link. This study was aimed to investigate effects and mechanisms in the treatment of myocardial fibrosis in hypertension with TCM from a different perspective, which provided references for clinical treatment.